MAS1L
geneOn this page
Also known as MAS-LMRGdJ994E9.2
Summary
MAS1L (MAS1 proto-oncogene like, G protein-coupled receptor, HGNC:13961) is a protein-coding gene on chromosome 6p22.1, encoding Mas-related G-protein coupled receptor MRG (P35410).
Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane.
Source: NCBI Gene 116511 — RefSeq curated summary.
At a glance
- GWAS associations: 21
- Clinical variants (ClinVar): 59 total
- Druggable target: yes
- MANE Select transcript:
NM_052967
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13961 |
| Approved symbol | MAS1L |
| Name | MAS1 proto-oncogene like, G protein-coupled receptor |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MAS-L, MRG, dJ994E9.2 |
| Ensembl gene | ENSG00000204687 |
| Ensembl biotype | protein_coding |
| OMIM | 607235 |
| Entrez | 116511 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377127
RefSeq mRNA: 1 — MANE Select: NM_052967
NM_052967
CCDS: CCDS4661
Canonical transcript exons
ENST00000377127 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001758596 | 29486697 | 29487956 |
Expression profiles
Bgee: expression breadth broad, 58 present calls, max score 57.06.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| smooth muscle tissue | UBERON:0001135 | 57.06 | gold quality |
| gall bladder | UBERON:0002110 | 56.64 | gold quality |
| rectum | UBERON:0001052 | 52.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 51.48 | gold quality |
| lower esophagus | UBERON:0013473 | 51.38 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 51.26 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 51.18 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 50.60 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 49.53 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 49.34 | silver quality |
| duodenum | UBERON:0002114 | 48.07 | gold quality |
| right coronary artery | UBERON:0001625 | 47.45 | gold quality |
| skin of abdomen | UBERON:0001416 | 46.43 | gold quality |
| zone of skin | UBERON:0000014 | 46.06 | gold quality |
| muscle tissue | UBERON:0002385 | 45.96 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.87 | gold quality |
| skin of leg | UBERON:0001511 | 45.82 | gold quality |
| esophagus | UBERON:0001043 | 45.59 | gold quality |
| adipose tissue | UBERON:0001013 | 45.38 | gold quality |
| minor salivary gland | UBERON:0001830 | 43.19 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 42.97 | gold quality |
| urinary bladder | UBERON:0001255 | 42.71 | gold quality |
| ectocervix | UBERON:0012249 | 42.67 | gold quality |
| mucosa of stomach | UBERON:0001199 | 41.95 | silver quality |
| uterine cervix | UBERON:0000002 | 41.34 | gold quality |
| small intestine | UBERON:0002108 | 40.80 | gold quality |
| fundus of stomach | UBERON:0001160 | 40.61 | gold quality |
| omental fat pad | UBERON:0010414 | 40.45 | gold quality |
| esophagus mucosa | UBERON:0002469 | 40.23 | gold quality |
| tibial nerve | UBERON:0001323 | 39.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Mas, MrgD, and MRG mediated Ang IV-stimulated AA release that was highest for Mas. While Ang III activated Mas and MrgX2, Ang II stimulated AA release via Mas and MRG. (PMID:18636314)
Cross-species orthologs
0 orthologs
Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRF (ENSG00000172935), MRGPRD (ENSG00000172938), GPR152 (ENSG00000175514), MRGPRX4 (ENSG00000179817), MRGPRX3 (ENSG00000179826), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MRGPRE (ENSG00000184350)
Protein
Protein identifiers
Mas-related G-protein coupled receptor MRG — P35410 (reviewed: P35410)
Alternative names: MAS1-like
All UniProt accessions (2): P35410, W8W3J1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family. Mas subfamily.
RefSeq proteins (1): NP_443199* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR026234 | MRGPCRFAMILY | Family |
UniProt features (21 total): topological domain 8, transmembrane region 7, glycosylation site 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P35410-F1 | 66.76 | 0.12 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 54, 57
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 13 (showing top):
WTGAAAT_UNKNOWN, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, MAFG_TARGET_GENES, WP_GPCRS_CLASS_A_RHODOPSINLIKE, WP_MALE_INFERTILITY, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN, MODULE_337, chr6p22, GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP, CEBP_C
GO Biological Process (2): G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165)
GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (4): nucleoplasm (GO:0005654), cytosol (GO:0005829), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MAS1L | NPFF | O15130 | 822 |
| MAS1L | ACE | P12821 | 811 |
| MAS1L | AGTR1 | P30556 | 790 |
| MAS1L | ACE2 | Q9BYF1 | 790 |
| MAS1L | AGT | P01019 | 761 |
| MAS1L | REN | P00797 | 720 |
| MAS1L | TMPRSS2 | O15393 | 479 |
| MAS1L | AGTR2 | P50052 | 447 |
| MAS1L | KNG1 | P01042 | 418 |
| MAS1L | BDKRB1 | P46663 | 393 |
| MAS1L | ADAM17 | P78536 | 376 |
| MAS1L | SLC3A1 | Q07837 | 372 |
| MAS1L | OR10C1 | Q96KK4 | 371 |
| MAS1L | ARGFX | A6NJG6 | 363 |
| MAS1L | RHOF | Q9HBH0 | 353 |
IntAct
1 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAS1L | rl36a_rl36l_human | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): RPL36AL (Affinity Capture-MS)
ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8
Diamond homologs: B9VR26, O55197, O88680, P04201, P12526, P23749, P30554, P35410, Q16581, Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5REI5, Q5U9D9, Q6L786, Q6TAC8, Q6XKD3, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q7TN51, Q86SM5, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8VCJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
293 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:29486952:C:CT | acceptor_gain | 0.8900 |
| 6:29487805:C:CC | acceptor_gain | 0.8400 |
| 6:29486952:C:T | acceptor_gain | 0.8300 |
| 6:29487803:CA:C | acceptor_gain | 0.8200 |
| 6:29487802:CCA:C | acceptor_gain | 0.8000 |
| 6:29487803:CAC:C | acceptor_gain | 0.8000 |
| 6:29487931:CA:C | donor_gain | 0.7800 |
| 6:29487932:A:AC | donor_gain | 0.7800 |
| 6:29487800:CACCA:C | acceptor_gain | 0.7000 |
| 6:29487928:CAACA:C | donor_gain | 0.7000 |
| 6:29487713:T:C | donor_gain | 0.6900 |
| 6:29486954:C:CT | acceptor_gain | 0.6600 |
| 6:29486955:A:T | acceptor_gain | 0.6400 |
| 6:29486983:C:CC | acceptor_gain | 0.6400 |
| 6:29487801:ACCAC:A | acceptor_loss | 0.6100 |
| 6:29487803:CACTG:C | acceptor_loss | 0.6100 |
| 6:29487804:ACTG:A | acceptor_loss | 0.6100 |
| 6:29487805:CTGT:C | acceptor_loss | 0.6100 |
| 6:29487806:T:G | acceptor_loss | 0.6100 |
| 6:29487807:G:C | acceptor_loss | 0.6100 |
| 6:29486987:T:TC | acceptor_gain | 0.6000 |
| 6:29487430:T:TG | acceptor_gain | 0.5900 |
| 6:29486978:CGCTG:C | acceptor_gain | 0.5800 |
| 6:29486980:CTG:C | acceptor_gain | 0.5800 |
| 6:29486948:TCCCC:T | acceptor_gain | 0.5700 |
| 6:29487913:G:T | donor_gain | 0.5700 |
| 6:29487808:TGGAG:T | acceptor_loss | 0.5600 |
| 6:29487809:GGAGA:G | acceptor_loss | 0.5600 |
| 6:29487814:C:CT | acceptor_loss | 0.5600 |
| 6:29486992:A:AC | acceptor_gain | 0.5500 |
AlphaMissense
2475 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:29486979:G:C | S308R | 0.951 |
| 6:29486979:G:T | S308R | 0.951 |
| 6:29486981:T:G | S308R | 0.951 |
| 6:29487399:G:C | S168R | 0.942 |
| 6:29487399:G:T | S168R | 0.942 |
| 6:29487401:T:G | S168R | 0.942 |
| 6:29487084:G:C | F273L | 0.938 |
| 6:29487084:G:T | F273L | 0.938 |
| 6:29487086:A:G | F273L | 0.938 |
| 6:29487174:A:C | S243R | 0.931 |
| 6:29487174:A:T | S243R | 0.931 |
| 6:29487176:T:G | S243R | 0.931 |
| 6:29487533:A:G | C124R | 0.915 |
| 6:29487296:A:G | C203R | 0.911 |
| 6:29487372:G:C | F177L | 0.911 |
| 6:29487372:G:T | F177L | 0.911 |
| 6:29487374:A:G | F177L | 0.911 |
| 6:29487438:G:C | F155L | 0.907 |
| 6:29487438:G:T | F155L | 0.907 |
| 6:29487440:A:G | F155L | 0.907 |
| 6:29487185:A:G | C240R | 0.905 |
| 6:29487311:A:G | W198R | 0.902 |
| 6:29487311:A:T | W198R | 0.902 |
| 6:29487321:G:C | C194W | 0.901 |
| 6:29487622:C:T | G94D | 0.901 |
| 6:29487623:C:G | G94R | 0.886 |
| 6:29487432:A:C | F157L | 0.885 |
| 6:29487432:A:T | F157L | 0.885 |
| 6:29487434:A:G | F157L | 0.885 |
| 6:29486977:G:T | A309D | 0.884 |
dbSNP variants (sampled 300 via entrez): RS1000009425 (6:29488355 TCACTG>T), RS1001537013 (6:29489527 G>A,C), RS1001651577 (6:29489379 A>G), RS1002408193 (6:29486623 A>C), RS1004890390 (6:29489047 A>G), RS1005266319 (6:29489357 G>T), RS1008687129 (6:29488745 C>G), RS1009173038 (6:29489185 T>C), RS1009759126 (6:29488669 G>A,C), RS1012135798 (6:29489601 T>C), RS1012249887 (6:29486330 A>T), RS1012279024 (6:29488291 T>C), RS1012630423 (6:29486614 G>A), RS1012766229 (6:29488004 G>A,T), RS1017556350 (6:29488457 G>A)
Disease associations
OMIM: gene MIM:607235 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
21 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002884_1 | Cutaneous lupus erythematosus | 8.000000e-10 |
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_171 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_263 | Autism spectrum disorder or schizophrenia | 7.000000e-17 |
| GCST004521_268 | Autism spectrum disorder or schizophrenia | 7.000000e-12 |
| GCST004521_295 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_43 | Autism spectrum disorder or schizophrenia | 2.000000e-27 |
| GCST004521_56 | Autism spectrum disorder or schizophrenia | 1.000000e-22 |
| GCST004521_58 | Autism spectrum disorder or schizophrenia | 1.000000e-17 |
| GCST004521_62 | Autism spectrum disorder or schizophrenia | 1.000000e-10 |
| GCST005541_8 | Sarcoidosis (Lofgren’s syndrome vs non-Lofgren’s syndrome) | 1.000000e-20 |
| GCST008745_56 | Estimated glomerular filtration rate in non-diabetics | 9.000000e-09 |
| GCST010002_46 | Refractive error | 2.000000e-20 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523857 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with emerging pharmacology
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol S | decreases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Folic Acid | decreases expression | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883522 | Binding | PRESTO-Tango GPCRome screening (MAS1L) | Data for DCP probe UCSF924 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cutaneous lupus erythematosus, sarcoidosis